leflunomide and 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone

leflunomide has been researched along with 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deorukhkar, A; Fernandes, CJ; Fleming, JB; Fujimoto, TN; Gupta, S; Herman, JM; Huang, Y; Kang, Y; Koay, EJ; Koong, AC; Lin, D; Maitra, A; Molkentine, JM; Nguyen, ND; San Lucas, FA; Taniguchi, CM; Ying, H; Yu, M	1

Other Studies

1 other study(ies) available for leflunomide and 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone

Article	Year
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. JCI insight, 2019, 07-23, Volume: 5 Topics: Animals; Carcinoma, Pancreatic Ductal; CRISPR-Cas Systems; Disease Models, Animal; Dynamins; Enzyme Inhibitors; GTP Phosphohydrolases; Leflunomide; Mice; Mice, Knockout; Mitochondria; Mitochondrial Dynamics; Mitophagy; Oxidative Phosphorylation; Pancreatic Neoplasms; Quinazolinones; Survival Rate	2019

Article

Year

Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer.

JCI insight, 2019, 07-23, Volume: 5

Topics: Animals; Carcinoma, Pancreatic Ductal; CRISPR-Cas Systems; Disease Models, Animal; Dynamins; Enzyme Inhibitors; GTP Phosphohydrolases; Leflunomide; Mice; Mice, Knockout; Mitochondria; Mitochondrial Dynamics; Mitophagy; Oxidative Phosphorylation; Pancreatic Neoplasms; Quinazolinones; Survival Rate

2019